Vocational Rehabilitation and Employment of People With Disabilities: Report of a European Conference

[From Overview] The European Conference on Vocational Rehabilitation and Employment of Persons with Disabilities was held in Warsaw, Poland, on 23-25 October 2003. The Conference was organized jointly by the Ministry of Economy, Labour and Social Policy of the Republic of Poland and the International Labour Organization’s Regional Office for Europe and Central Asia in Geneva and Subregional Office in Budapest, in cooperation with the Central European Initiative. The overall purpose of the European Conference was to review the progress of legislation and practice over the past ten years in the field of vocational rehabilitation of persons with disabilities and the improvement of their labour market situation, particularly in countries in the process of transition; to discuss issues connected with the adjustment to European Union standards of legislation on the vocational rehabilitation and employment of persons with disabilities; and to develop recommendations that would provide guidelines for activities and instruments aimed at promoting the vocational activity of persons with disabilities and supporting their employment

'The Disabled Persons (Employment) Act 1944: Registration'

Pamphlet produced by the Ministry of Labour and National Service

'Second Report of the Standing Committee on the Rehabilitation and Resettlement of Disabled Persons'

Produced by Ministry of Labour and National Service

'Training and Resettlement of Disabled Persons'

Pamphlet produced by the Ministry of Labour and National Service

'The Disabled Persons (Employment) Act 1944: Employment of the Deaf and Partially Deaf''

Guidance notes produced by the Ministry of Labour and National Service

Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis

Aims: Estimating the monetary value of the convenience of using influenza antivirals approved in Japan from a patient perspective using a conjoint analysis. Methods: An online survey (August 2020) was performed on individuals aged 20–64 years living in Japan who had taken oral or inhalant antivirals for influenza treatment in the 2018/19 or 2019/20 seasons. Efficacy and safety were assumed to be equivalent among the antivirals. The attributes for the conjoint analysis included route (oral or inhalant), duration, frequency of administration, and out-ofpocket expenses. A conditional logit model was applied as a baseline model. The monetary value of each attribute was calculated by comparing the same utility of the linearly interpolated level of the out-of-pocket attribute. Another survey to determine the experiences of the latest antiviral intake was also conducted on the same respondents. Results: Of the respondents, 1,550 were men and 1,587 were women. The monetary value for oral antivirals was estimated to be higher, saving JPY 741 (USD 7.06, as of August 2020), compared with inhalant. Regarding the length and frequency of administration, five days corresponds to an increase of JPY 2,072, compared with one day, and twice a day corresponds to a JPY 574 increase compared to once a day. Conclusions: The results suggest that – among the antivirals approved in Japan – the monetary value of the utility is the highest in the single dose oral antiviral, baloxavir marboxil (baloxavir). Although the drug cost was highest in baloxavir among the brand antivirals, the difference in the value of utility for influenza patient was estimated to be larger than the difference in the drug costs. Limitations: Although individuals with diverse attributes from all over the country were included in the survey, they are not necessarily a representative population of the Japanese society

Structure of Social Services in the Czech Republic; The Structure of Social Services — current status in the Czech Republic

A report on social services in the Czech RepublicInternational Labour Organizationunpublishe

Radiation Exposure from CT Examinations in Japan

<p>Abstract</p> <p>Background</p> <p>Computed tomography (CT) is the largest source of medical radiation exposure to the general population, and is considered a potential source of increased cancer risk. The aim of this study was to assess the current situation of CT use in Japan, and to investigate variations in radiation exposure in CT studies among institutions and scanners.</p> <p>Methods</p> <p>Data-sheets were sent to all 126 hospitals and randomly selected 14 (15%) of 94 clinics in Gunma prefecture which had CT scanner(s). Data for patients undergoing CT during a single month (June 2008) were obtained, along with CT scan protocols for each institution surveyed. Age and sex specific patterns of CT examination, the variation in radiation exposure from CT examinations, and factors which were responsible for the variation in radiation exposure were determined.</p> <p>Results</p> <p>An estimated 235.4 patients per 1,000 population undergo CT examinations each year, and 50% of the patients were scanned in two or more anatomical locations in one CT session. There was a large variation in effective dose among hospitals surveyed, particularly in lower abdominal CT (range, 2.6-19.0 mSv). CT examinations of the chest and upper abdomen contributed to approximately 73.2% of the collective dose from all CT examinations. It was estimated that in Japan, approximately 29.9 million patients undergo CT annually, and the estimated annual collective effective dose in Japan was 277.4 *10³Sv person. The annual effective dose per capita for Japan was estimated to be 2.20 mSv.</p> <p>Conclusions</p> <p>There was a very large variation in radiation exposure from CT among institutions surveyed. CT examinations of the chest and upper abdomen were the predominant contributors to the collective dose.</p